BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/16/2025 10:38:30 AM | Browse: 114 | Download: 523
 |
Received |
|
2025-02-05 03:58 |
|
Peer-Review Started |
|
2025-02-05 03:58 |
|
First Decision by Editorial Office Director |
|
2025-02-18 07:38 |
|
Return for Revision |
|
2025-02-18 07:38 |
|
Revised |
|
2025-03-04 01:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-04-14 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-04-14 09:40 |
|
Articles in Press |
|
2025-04-14 09:40 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-06-06 07:57 |
|
Publish the Manuscript Online |
|
2025-06-16 10:38 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Evidence Review |
| Article Title |
Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rahiya Rehman |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rahiya Rehman, Assistant Professor, MD, Department of Pediatric Gastroenterology, Saint Louis University, 1465 S Grand Blvd, Saint Louis, MO 63108, United States. rahiya.rehman@health.slu.edu |
| Key Words |
Pediatrics; Obesity; Metabolic dysfunction-associated steatotic liver disease; Glucagon-like peptide-1; Glucagon like peptide |
| Core Tip |
Understanding the impact of glucagon-like peptide-1 analogs in the pediatric population is crucial, as these medications have the potential to address a significant treatment gap in childhood metabolic disorders. Their effects on weight regulation, insulin sensitivity, and liver health could offer long-term benefits, particularly in conditions such as obesity, type 2 diabetes, and metabolic dysfunction associated steatotic liver disease. Further research and clinical trials are needed to establish their safety, efficacy, and appropriate use in children. |
| Publish Date |
2025-06-16 10:38 |
| Citation |
Rehman R. Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease. World J Clin Pediatr 2025; 14(3): 105731 |
| URL |
https://www.wjgnet.com/2219-2808/full/v14/i3/105731.htm |
| DOI |
https://dx.doi.org/10.5409/wjcp.v14.i3.105731 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
